This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

A Pathophysiologic Basis for Evidence-Based Treatments of Moderate-Severe Atopic Dermatitis

A Pathophysiologic Basis for Evidence-Based Treatments of Moderate-Severe Atopic Dermatitis

Format

Webcast

Time to Complete

1.25 hours

Released

May 31, 2019

Expires

May 30, 2020
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 CreditsTM
1.25 / CNE Contact Hours
1.25 / AANP Contact Hours

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

In this subway-themed activity you can choose different subway lines for the education that is the most relevant to you. In this activity, Alan Fleischer, Jr, MD, and Lindsay Strowd, MD, discuss the evolution in targeted treatments for atopic dermatitis based on improved understanding of pathophysiologic mechanisms. Supported by patient vignettes, they provide strategies for assessing the patient disease burden and its importance in developing an individualized treatment plan. Suggestions for greater patient engagement and improved self-management are also provided. The role and use of evidence-based nonpharmacologic and pharmacologic therapies are reviewed, focusing on dupilumab, for moderate-severe atopic dermatitis.

Intended Audience

This activity is intended for dermatologists, pediatric dermatologists, allergists, along with nurse practitioners and physician assistants within those specialties who manage patients with atopic dermatitis.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Describe the current understanding of the pathophysiology of atopic dermatitis
  • Conduct a thorough assessment, including differential diagnosis, to establish the diagnosis and severity of atopic dermatitis
  • Develop treatment plans that address both symptoms and patient concerns
  • Integrate evidence-based therapies for moderate-severe atopic dermatitis into treatment plans
  • Identify and manage comorbidities of atopic dermatitis and treatment-related complications

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Faculty

Alan B. Fleischer, Jr, MD
Professor and Residency Program Director
Department of Dermatology
University of Cincinnati College of Medicine
Cincinnati, Ohio

Dr. Fleischer discloses the following:
Former Employee: AbbVie- clinical area: Atopic dermatitis, psoriasis
Consultant: Dermavant- clinical area: Atopic dermatitis; Qurient- clinical area: Atopic dermatitis

Lindsay C. Strowd, MD, FAAD
Assistant Professor of Dermatology
Wake Forest Baptist Health
Winston-Salem, North Carolina

Dr. Strowd discloses the following:
Research Support: Galderma- clinical area: Atopic dermatitis; Pfizer- clinical area: Atopic dermatitis
Consultant: Actelion- clinical area: Mycosis fungoides; Sanofi- clinical area: Atopic dermatitis; Regeneron- clinical area: Atopic dermatitis

Accredited Provider Disclosure

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Publishing Staff Disclosures

The following have no significant relationship to disclose:

Additional content planners
Greg Scott, RPH, PharmD (medical writer)
Eugene Cullen, MD (peer reviewer)
Heather Jimenez, NP (nurse planner)

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.25

Type

CNE Contact Hour(s)

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.25 contact hours. To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.

Credit

1.25

Type

CE for Nurse Practitioners

Accreditation Statement

Annenberg Center for Health Sciences at Eisenhower is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

Designation Statement

This program is accredited for 1.25 contact hours. Program ID #5738-EM

Disclosure of Unlabeled Use

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material, reflecting on its implications for your practice, and completing the assessment component.

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue